Streptococcus sanguinis (S. sanguinis) is a leading cause of infective endocarditis (IE) that cause a wide range of clinical manifestations including death. It utilizes the PilA protein (a key component of type IV pili) to mediate strong adhesion and biofilm formation in heart tissues. Such biofilms exhibit resistance to traditional antibiotics like penicillin G and vancomycin. The standard treatment with these antibiotics are often ineffective owing to poor biofilm penetration leading to persistent infection and antibiotic resistance. Therefore, targeting PilA offers a potential strategy for disrupting biofilm formation and enhancement of IE treatment. The present in silico study is designed to evaluate Quercetin and its derivatives as a safer and alternative strategy to combat S. sanguinis-mediated biofilm formation. Molecular docking analyses demonstrated that Quercetin (-6.5 kcal/mol) and 8-prenylquercetin (-6.6 kcal/mol) exhibited stronger binding to the PilA protein of S. sanguinis compared to Penicillin G (-6.5 kcal/mol), indicating their superior potential in disrupting biofilm formation. Dynamic simulation further confirmed the stability of these complexes over time, suggesting persistent interaction with the target site. Pharmacokinetic evaluation also revealed favourable absorption, distribution, and metabolic properties, while toxicity prediction showed minimal adverse effects. Overall, the study highlights that Quercetin and its derivatives may serve as promising antibiofilm candidates against S. sanguinis. However, experimental validation through in vitro and in vivo studies is warranted to confirm their biological efficacy and safety.
扫码关注我们
求助内容:
应助结果提醒方式:
